Toughening of complete solid solution cermets by graphite addition

(Ti0.95Ta0.05)(C0.5N0.5)-Co complete solid solution cermets (CSCs) were developed by a mechanochemical synthesis process and a pressureless sintering method. The effect of different percentages of graphite used as a sintering additive on the nature of the binder phase and the mechanical properties of the cermets was investigated. Microstructural and mechanical characterisations were carried out by X-ray diffraction, optical microscopy, scanning electron microscopy, transmission electron microscopy, energy-dispersive X-ray spectroscopy, Vickers hardness, indentation fracture toughness and nanoindentation. The addition of graphite modified the carbon activity during sintering, reducing the dissolution of carbonitride ceramic particles into the molten binder. The amount of Ti and Ta remaining in the binder after sintering gradually decreased as the amount of graphite added increased, which induced a change in the nature of the binder phase. When no graphite was added, the binder consisted of the brittle TixTa1-xCo2 intermetallic phase. With the increase in the amount of graphite added, the formation of more ductile phases, such as TixTa1-xCo3 and α-Co, was observed, causing a significant improvement in the toughness of the cermets.Peer reviewe

Hot-Pressing of (Ti, Mt)(C, N)-Co-Mo2C (Mt=Ta, Nb) powdered cermets synthesized by a mechanically induced self-sustaining reaction

A mechanically induced self-sustaining reaction (MSR) has been successfully employed for manufacturing powdered cermets based on Ti, Ti–Ta and Ti–Nb carbonitrides using Co as the binder phase and Mo2C as the sintering additive. The powders were sintered by hot-pressing, and complete chemical, microstructural and mechanical characterizations were performed on the densified cermets. When elemental Ta, Nb and/or Mo2C were added to the initial raw mixture submitted to the MSR process, smaller ceramic grains were observed after sintering, which suggested that ceramic particle growth was hindered by the presence of Ta, Nb and/or Mo in the host titanium carbonitride structure. Nanoindentation measurements enabled the determination of the hardness of the ceramic and binder phases, and values in the range of 26–29 GPa and 14–16 GPa were found, respectively. The high hardness values of the binder were related to the formation of intermetallic phases.Gobierno de España European Regional Development No. MAT2011- 2298

In vitro irradiation system for radiobiological experiments

Background: Although two-dimensional (2-D) monolayer cell cultures provide important information on basic tumor biology and radiobiology, they are not representative of the complexity of three-dimensional (3-D) solid tumors. In particular, new models reproducing clinical conditions as closely as possible are needed for radiobiological studies to provide information that can be translated from bench to bedside. Methods: We developed a novel system for the irradiation, under sterile conditions, of 3-D tumor spheroids, the in vitro model considered as a bridge between the complex architectural organization of in vivo tumors and the very simple one of in vitro monolayer cell cultures. The system exploits the same equipment as that used for patient treatments, without the need for dedicated and highly expensive instruments. To mimic the passage of radiation beams through human tissues before they reach the target tumor mass, 96-multiwell plates containing the multicellular tumor spheroids (MCTS) are inserted into a custom-built phantom made of plexiglass, the material most similar to water, the main component of human tissue. Results: The system was used to irradiate CAEP- and A549-derived MCTS, pre-treated or not with 20 \u3bcM cisplatin, with a dose of 20 Gy delivered in one session. We also tested the same treatment schemes on monolayer CAEP and A549 cells. Our preliminary results indicated a significant increment in radiotoxicity 20 days after the end of irradiation in the CAEP spheroids pre-treated with cisplatin compared to those treated with cisplatin or irradiation alone. Conversely, the effect of the radio- chemotherapy combination in A549-derived MCTS was similar to that induced by cisplatin or irradiation alone. Finally, the 20 Gy dose did not affect cell survival in monolayer CAEP and A549 cells, whereas cisplatin or cisplatin plus radiation caused 100% cell death, regardless of the type of cell line used. Conclusions: We set up a system for the irradiation, under sterile conditions, of tumor cells grown in 3-D which allows for the use of the same dose intensities and schedules utilized in clinical practice. This irradiation system, coupled with 3-D cell cultures, has the potential to generate information that could be used to individually tailor radiotherap

Ocorrência de tatu-de-rabo-mole, Cabassous unicinctus (Cingulata, Dasypodidae) no Pantanal, Brasil.

Há poucos registros na literatura científica sobre a ocorrência de tatu-de-rabo-mole (Cabassous unicinctus) na planície do Pantanal e nos planaltos adjacentes. Entretanto, dados relativamente recentes com base em espécimes coletados, registros fotográficos e observações de campo revelam que a espécie tem ampla distribuição na porção sul da planície, em regiões como Pantanal da Nhecolândia e Paiaguás, bem como no entorno do Pantanal (Diamantino, Taboco, Coxim, Terenos, Aquidauna, Bodoquena e Rochedo). A espécie apresenta ampla plasticidade ecológica em relação ao uso de habitat, sendo registrada tanto em campos com pastagens cultivadas (Brachiaria spp.), quanto campos inundáveis, capões, cerradão e cerrado. Com base em comparação dos exemplares fotografados no Pantanal e áreas do entorno com dados literários, verificou-se que os mesmos pertencem à subespécie Cabassous unicinctus squamicaudis.bitstream/CPAP-2010/57165/1/BP87.pd

Molecular, anatomical and physiological properties of a genetically modified soybean line transformed with rd29A:AtDREB1A for the improvement of drought tolerance.

We evaluated the molecular, anatomical and physiological properties of a soybean line transformed to improve drought tolerance with an rd29A:AtDREB1A construct. This construct expressed dehydration- responsive element binding protein DREB1A from the stress-inducible rd29A promoter. The greenhouse growth test included four randomized blocks of soybean plants, with each treatment performed in triplicate. Seeds from the non-transformed soybean cultivar BR16 and from the genetically modified soybean P58 line (T2 generation) were grown at 15% gravimetric humidity for 31 days. To induce water deficit, the humidity was reduced to 5% gravimetric humidity (moderate stress) for 29 days and then to 2.5% gravimetric humidity (severe stress). AtDREB1A gene expression was higher in the genetically modified P58 plants during water deficit, demonstrating transgene stability in T2 generations and induction of the rd29A promoter. Drought-response genes, including GmPI-PLC, GmSTP, GmGRP, and GmLEA14, were highly expressed in plants submitted to severe stress. Genetically modified plants had higher stomatal conductance and consequently higher photosynthetic and transpiration rates. In addition, they had more chlorophyll. Overexpression of AtDREB1A may contribute to a decrease in leaf thickness; however, a thicker abaxial epidermis was observed. Overexpression of AtDREB1A in soybean appears to enhance drought tolerance

Tumour microvessel density as predictor of chemotherapy response in breast cancer patients

The aim of this study was to evaluate the predictive value of intratumoural microvessel density in breast cancer. We studied immunohistochemically primary tumours of 104 patients with metastasised breast cancer who took part in a randomised multicentre trial comparing docetaxel to sequential methotrexate and 5-fluorouracil. Vessels were highlighted with factor VIII staining and counted microscopically. Microvessel density was compared with clinical response to chemotherapy and patient survival. The microvessel density of the primary tumour was not significantly associated with patient's response to chemotherapy, time to progression or overall survival in the whole patient population or in the docetaxel or methotrexate and 5-fluorouracil groups. However, disease-free survival was longer in patients with low microvessel density (P=0.01). These findings suggest that microvessel density of the primary tumour cannot be used as a predictive marker for chemotherapy response in advanced breast cancer

Prognostic significance of microvessel density and other variables in Japanese and British patients with primary invasive breast cancer

The purpose of this study is to investigate the associations of microvessel density (MVD) and other pathological variables with survival, and whether they accounted for survival differences between Japanese and British patients. One hundred seventy-three Japanese and 184 British patients were included in the study. British patients were significantly older (56.3±11.4 years vs 52.5±12.9 years; P<0.01) and had smaller tumours (2.2±1.3 vs 2.7±1.8 cm; P<0.01), which were more frequently oestrogen receptor positive (78.8 vs 57.2%, P<0.01), had more grade III tumours (29.9 vs 21.4%, P=0.04) and more infiltrating lobular carcinomas (13.6 vs 4.0%, P<0.01) and a higher MVD compared with Japanese patients (57.9±19.8 vs 53.2±18.6; P=0.01). However, no difference in the prevalence of lymph-node metastasis was found between them (39.1 vs 37.5%, P=0.75). Younger British patients (age <50 years) had the highest MVD compared with Japanese and older British patients (P<0.01). Japanese patients were proportionately more likely to receive chemotherapy than endocrine therapy (P<0.01). British patients had a significantly worse relapse-free survival and overall survival compared with Japanese patients, after statistical adjustment for variables (hazard ratio=2.1, 2.4, P<0.01, P<0.01, respectively), especially, in T2 stage, low MVD and older subgroup (HR: 3.6, 5.0; 3.1, 3.3; 3.2, 3.9, respectively), but only in ER negative cases (P=0.04, P=0.01, respectively). The present study shows that MVD contributes to the Japanese–British disparity in breast cancer. However, the MVD variability did not explain the survival differences between Japanese and British patients